Swedish Biotech Breakthroughs

Ascelia Pharma

Market Cap: SEK 354.0m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Guard Therapeutics International

Market Cap: SEK 35.9m

A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.

Initiator Pharma

Market Cap: SEK 196.5m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Xspray Pharma

Market Cap: SEK 968.4m

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 6.5m

A clinical-stage pharmaceutical company, develops drugs for lipid related diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.8b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Active Biotech

Market Cap: SEK 101.2m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Diamyd Medical

Market Cap: SEK 2.3b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

SynAct Pharma

Market Cap: SEK 1.2b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Vitrolife

Market Cap: SEK 12.3b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.